X0407 4 2023-06-12 0 0001797768 Kinnate Biopharma Inc. KNTE 0001282930 GORDON CARL L 103 MONTGOMERY STREET, SUITE 150 THE PRESIDIO OF SAN FRANCISCO SAN FRANCISCO CA 94129 1 0 1 0 0 Stock Option (right to buy) 3.48 2023-06-12 4 A 0 25000 0.00 A 2033-06-12 Common Stock 25000 25000 D 1/12th of the shares underlying the Option vest and become exercisable on a monthly basis starting July 12, 2023 (the Vest Base Date) and thereafter on the same day of the month as the Vest Base Date or if earlier, the day immediately before the date of the next Annual Meeting of Stockholders that occurs after the Vest Base Date. Pursuant to an agreement with OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, and OrbiMed Capital GP VIII LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, and OrbiMed Capital GP VIII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP and OrbiMed Private Investments VIII, LP. /s/ Mark A. Meltz, as attorney-in-fact 2022-06-13